Literature DB >> 17965622

Histone H3 and H4 modification profiles in a Rett syndrome mouse model.

Rocio G Urdinguio1, Irene Pino, Santiago Ropero, Mario F Fraga, Manel Esteller.   

Abstract

Rett syndrome (RTT) is a complex neurodevelopmental disorder that has been associated with mutations of methyl-CpG binding protein 2 (MeCP2). MeCP2 acts as a transcriptional repressor and binds to histone modifier proteins, which prompted us to wonder whether MeCP2 disruption affects global histone modification patterns. Taking a two-fold approach of using high-performance capillary electrophoresis (HPCE) and western blot, we analyzed the acetylation and methylation status of histones H3 and H4 in a mouse model of RTT where the MeCP2 locus is genetically disrupted. The comparison of cortex, midbrain and cerebellum in wild-type and MeCP2-knock out mice did not reveal any significant difference in the global H3 and H4 histone modification patterns. Our results suggest that MeCP2 deficiency involves local and gene-specific chromatin changes rather than massive histone modification changes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17965622     DOI: 10.4161/epi.2.1.3698

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  5 in total

1.  Setdb1-mediated histone H3K9 hypermethylation in neurons worsens the neurological phenotype of Mecp2-deficient mice.

Authors:  Yan Jiang; Anouch Matevossian; Yin Guo; Schahram Akbarian
Journal:  Neuropharmacology       Date:  2010-09-30       Impact factor: 5.250

2.  Mutation of MeCP2 alters transcriptional regulation of select immediate-early genes.

Authors:  Dan Su; Young May Cha; Anne E West
Journal:  Epigenetics       Date:  2012-02       Impact factor: 4.528

Review 3.  Recent advances in MeCP2 structure and function.

Authors:  Kristopher C Hite; Valerie H Adams; Jeffrey C Hansen
Journal:  Biochem Cell Biol       Date:  2009-02       Impact factor: 3.626

Review 4.  Non-coding RNAs in chromatin disease involving neurological defects.

Authors:  Floriana Della Ragione; Miriam Gagliardi; Maurizio D'Esposito; Maria R Matarazzo
Journal:  Front Cell Neurosci       Date:  2014-02-25       Impact factor: 5.505

Review 5.  MeCP2: The Genetic Driver of Rett Syndrome Epigenetics.

Authors:  Katrina V Good; John B Vincent; Juan Ausió
Journal:  Front Genet       Date:  2021-01-21       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.